J-P Tassin - JoVE Visualize

Showing results (11-20 of 65) with videos related to

Pageof 7

Sort By:

The Journal of Pharmacology and Experimental Therapeutics|May 1, 1992

Nicotine and morphine differentially activate brain dopamine in prefrontocortical and subcortical terminal fields: effects of acute and repeated injectionsP Vezina, G Blanc, J Glowinski, et al.

Brain Research|January 23, 1999

Ginkgo biloba extract EGb761 reduces the development of amphetamine-induced behavioral sensitization: effects on hippocampal type II corticosteroid receptorsF Trovero, D Brochet, J P Tassin, et al.

Neuroscience Letters|February 28, 1994

Injections of 6-hydroxydopamine into the ventral tegmental area destroy mesolimbic dopamine neurons but spare the locomotor activating effects of nicotine in the ratP Vezina, D Hervé, J Glowinski, et al.

Brain Research|April 15, 1982

Reduction of dopamine utilization in the prefrontal cortex but not in the nucleus accumbens after selective destruction of noradrenergic fibers innervating the ventral tegmental area in the ratD Herve, G Blanc, J Glowinski, et al.

The European Journal of Neuroscience|January 1, 1991

Opposed Behavioural Outputs of Increased Dopamine Transmission in Prefrontocortical and Subcortical Areas: A Role for the Cortical D-1 Dopamine ReceptorP. Vezina, G. Blanc, J. Glowinski, et al.

Journal of Clinical Pharmacy and Therapeutics|December 21, 2000

Sequential improvement of anxiety, depression and anhedonia with sertraline treatment in patients with major depressionP Boyer, J P Tassin, B Falissart, et al.

Synapse (New York, N.Y.)|February 1, 1994

Blockade of D-1 dopamine receptors in the medial prefrontal cortex produces delayed effects on pre- and postsynaptic indices of dopamine function in the nucleus accumbensP Vezina, G Blanc, J Glowinski, et al.

Journal of Chromatography. B, Biomedical Sciences and Applications|April 11, 1997

Simultaneous determination of cytotoxic (adriamycin, vincristine) and modulator of resistance (verapamil, S 9788) drugs in human cells by high-performance liquid chromatography and ultraviolet detectionJ P Tassin, J Dubois, G Atassi, et al.

Talanta|May 1, 1995

HPLC determination of a new multidrug resistance modulator (S9788) extracted from cancer cells in vitroJ P Tassin, J Dubois, M Hanocq, et al.

Brain Research|December 3, 1984

Topographical distributions of 32K and 48K cAMP-regulated phosphoproteins: relationships to dopamine and serotonin innervations in striatum, substantia nigra and cerebral cortexJ R Lemos, C Barberis, J P Tassin, et al.

Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:

Pageof 7

The Journal of Pharmacology and Experimental Therapeutics|May 1, 1992

Nicotine and morphine differentially activate brain dopamine in prefrontocortical and subcortical terminal fields: effects of acute and repeated injectionsP Vezina, G Blanc, J Glowinski, et al.

Brain Research|January 23, 1999

Ginkgo biloba extract EGb761 reduces the development of amphetamine-induced behavioral sensitization: effects on hippocampal type II corticosteroid receptorsF Trovero, D Brochet, J P Tassin, et al.

Neuroscience Letters|February 28, 1994

Injections of 6-hydroxydopamine into the ventral tegmental area destroy mesolimbic dopamine neurons but spare the locomotor activating effects of nicotine in the ratP Vezina, D Hervé, J Glowinski, et al.

Brain Research|April 15, 1982

Reduction of dopamine utilization in the prefrontal cortex but not in the nucleus accumbens after selective destruction of noradrenergic fibers innervating the ventral tegmental area in the ratD Herve, G Blanc, J Glowinski, et al.

The European Journal of Neuroscience|January 1, 1991

Opposed Behavioural Outputs of Increased Dopamine Transmission in Prefrontocortical and Subcortical Areas: A Role for the Cortical D-1 Dopamine ReceptorP. Vezina, G. Blanc, J. Glowinski, et al.

Journal of Clinical Pharmacy and Therapeutics|December 21, 2000

Sequential improvement of anxiety, depression and anhedonia with sertraline treatment in patients with major depressionP Boyer, J P Tassin, B Falissart, et al.

Synapse (New York, N.Y.)|February 1, 1994

Blockade of D-1 dopamine receptors in the medial prefrontal cortex produces delayed effects on pre- and postsynaptic indices of dopamine function in the nucleus accumbensP Vezina, G Blanc, J Glowinski, et al.

Journal of Chromatography. B, Biomedical Sciences and Applications|April 11, 1997

Simultaneous determination of cytotoxic (adriamycin, vincristine) and modulator of resistance (verapamil, S 9788) drugs in human cells by high-performance liquid chromatography and ultraviolet detectionJ P Tassin, J Dubois, G Atassi, et al.

Talanta|May 1, 1995

HPLC determination of a new multidrug resistance modulator (S9788) extracted from cancer cells in vitroJ P Tassin, J Dubois, M Hanocq, et al.

Brain Research|December 3, 1984

Topographical distributions of 32K and 48K cAMP-regulated phosphoproteins: relationships to dopamine and serotonin innervations in striatum, substantia nigra and cerebral cortexJ R Lemos, C Barberis, J P Tassin, et al.

Pageof 7